Metellus AG acts as the conductor for our investments, guiding them from start-up to IPO. We specialise in deep tech and biotech, focusing on disruptive technologies with global potential. As founders and principal investors, we take an active role in shaping strategy and strengthening boards and leadership teams. We collaborate with leading universities and institutions worldwide to source talent, validate science, and accelerate growth.

<10

-

-

-

QuantalRF, Revolo Biotherapeutics Limited, iZettle

2008

Independent Private Partnership

-

Biotechnology, Chemical - Materials, Internet Technology, Medical - Life Sciences - Health Related, Telecommunications, Communications other

North America, Western Europe

Equity Financing

-

-

-

-